Skip to main content
Log in

The effects of quinpirole and fenoldopam on the potassium-evoked overflow of endogenous dopamine and noradrenaline in dog mesenteric arteries

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

(1) Dopamine and noradrenaline overflow from the main trunk of the dog mesenteric artery and its proximal branches, elicited by K+ (52 mmol/l), was measured by high pressure liquid chromatography with electrochemical detection. (2) Quinpirole (0.1, 1 and 10 nmol/l) produced a concentration dependent reduction of dopamine and noradrenaline overflow in both segments of the mesenteric artery. The inhibitory effect of quinpirole (10 nmol/l) on amine overflow was antagonized by sulpiride (1 μmol/l) but not by phentolamine (0.2 μmol/l) or the selective dopamine (DA1), antagonist SK&F 83566 (1 μol/l). (3) Fenoldopam (0.1 and 1 μmol/l) did not alter dopamine and noradrenaline overflow from both segments of the mesenteric artery; only 10 μmol/l fenoldopam was found to increase the overflow of dopamine and noradrenaline in both segments of the mesenteric artery. This effect of fenoldopam on amine overflow was not altered by the addition to the perifusion fluid of SK&F 83566 (1 μol/l). (4) Clonidine (100 nmol/l) significantly reduced amine overflow from both segments of the mesenteric artery and this effect was antagonized by fenoldopam (10 μmol/l) (5) These results suggest that quinpirole inhibits sympathetic neurotransmission through the activation of prejunctional dopamine receptors of the DA2 subtype. The facilitatory effect of fenoldopam (10 μmol/l) on amine release appears to be mediated through the blockade of prejunctional α2-adrenoceptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Azevedo I, Soares-da-Silva P (1981) Are fibroblasts adrenergically inervated cells? Blood Vessels 18:330–332

    Google Scholar 

  • Berkowitz BA, Zabko-Potapovich B, Sherman S, Hieble JP, Weinstock J, Ohlstein EH (1984) Vascular effects of SK&F 83566: a selective dopamine (DA-1) receptor antagonist. Fed Proc 43:743

    Google Scholar 

  • Berkowitz BA, Sherman S, Ohlstein EH (1985) Utility and selectivity of vascular dopamine (DA-1) receptor antagonists. In: Bevan JA, Godfraind T, Maxwell RA, Stoclet JC, Worcel M (eds) Vascular Neuroeffector Mechanisms: 5th International Symposium. Elsevier, Oxford, pp 227–234

    Google Scholar 

  • Bevan JA (1978) Norepinephrine and the presynaptic control of adrenergic transmitter release. Fed Proc 37:187–190

    Google Scholar 

  • Brodde O-E (1982) Vascular dopamine receptors: Demonstration and characterization by in vitro studies. Life Sci 31:289–306

    Google Scholar 

  • Dupont AG, Lefebvre RA, Vanderniepen P (1987) Influence of the dopamine agonists fenoldopam and quinpirole in the rat superior mesenteric superior vascular bed. Br J Pharmacol 91:493–501

    Google Scholar 

  • Foley JJ, Saran HM (1984) Adrenergic binding studies of SK&F 82526 and its enantiomers. Fed Proc 43:555

    Google Scholar 

  • Goldberg LI, Volkman PH, Kohli JD (1978) A comparison of the vascular dopamine receptor with other dopamine receptors. Ann Rev Pharmacol Toxicol 18:57–79

    Google Scholar 

  • Hahn RA, Wardell JR, Saran HM, Ridley PT (1982) Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist. J Pharmacol Exp Ther 223:305–313

    Google Scholar 

  • Hilditch A, Drew GM (1985) Peripheral dopamine receptor subtypes — a closer look. Trends Pharmacol Sci 6: 396–400

    Google Scholar 

  • Kohli JD, Glock D, Goldberg LI (1988) Relative DA1-receptor agonist and a-adrenoceptor antagonistic activity of fenoldopam in the anesthetized dog. J Cardiovasc Pharmacol 11:123–126

    Google Scholar 

  • Langer SZ (1981) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32:337–362

    Google Scholar 

  • Langer SZ, Vidal M, Duval N (1987) Presynaptic dopamine receptors in the cardiovascular system. Clin Exp Hypertension A9:837–851

    Google Scholar 

  • Lokhandwala MF, Barrett RJ (1982) Cardiovascular dopamine receptors: Physiological, pharmacological and therapeutic implications. J Anton Pharmacol 3:189–215

    Google Scholar 

  • Lokhandwala MF, Steenberg ML (1984) Evaluation of the effects of SK&F 82526 and LY 171555 on presynaptic DA2 and postsynaptic (DAj) dopamine receptors in rat kidney. J Anton Pharmacol 4:273- 277

    Google Scholar 

  • Ohlstein EH, Zabko-Potapovich B, Berkowitz BA (1984) Studies on vascular dopamine receptors with the dopamine receptor agonist: SK&F 82526. J Pharmacol Exp Ther 229:433–439

    Google Scholar 

  • Ohlstein EH, Zabko-Potapovich B, Berkowitz BA (1985) The DA1-receptor agonist fenoldopam (SK&F 82526) is also an α2-adrenoceptor antagonist. Eur J Pharmacol 118:321–329

    Google Scholar 

  • Sengupta S, Lokhandwala MF (1985) Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anesthetized rats. J Anton Pharmacol 5:289–294

    Google Scholar 

  • Shebuski RJ, Fujita T, Smith JM, Kopaciewicz LJ, Blumberg AL, Hieble JP (1985) Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog. J Pharmacol Exp Ther 235:735–740

    Google Scholar 

  • Soares-da-Silva P (1986) Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery. Naunyn-Schmiedeberg's Arch Pharmacol 333:219–223

    Google Scholar 

  • Soares-da-Silva P (1987a) A comparison between the pattern of dopamine and noradrenaline release from sympathetic neurones of the dog mesenteric artery. Br J Pharmacol 90: 91–98

    Google Scholar 

  • Soares-da-Silva P (1987b) Dopamine released from nerve terminals activates prejunctional dopamine receptors in dog mesenteric arterial vessels. Br J Pharmacol 91:591–599

    Google Scholar 

  • Soares-da-Silva P (1988a) Dopamine and noradrenergic transmission. In: Vanhoutte PM (ed) Mechanisms of Vasodilatation. Raven Press, New York, pp 187–195

    Google Scholar 

  • Soares-da-Silva P (1988b) Evidence for dopaminergic co-transmission in dog mesenteric arterial vessels. Br J Pharmacol 95:218–224

    Google Scholar 

  • Soares-da-Silva P, Azevedo I (1985) Fibroblasts and sympathetic innervation of blood vessels. Blood Vessels 22: 278–285

    Google Scholar 

  • Soares-da-Silva P, Davidson R (1985) Effects of 6-hydroxydopamine on dopamine and noradrenaline content in dog blood vessels and heart. Evidence for a noradrenaline-independent dopamine pool. Nauny-Schmiedeberg's Arch Pharmacol 329:253–257

    Google Scholar 

  • Sokal RR, Rohlf FJ (1981) Biometry. The principles and practice of statistics in biological research. Freeman and Company, New York

    Google Scholar 

  • Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124

    Google Scholar 

  • Starke K (1987) Presynaptic a-autoreceptors. Rev Physiol Biochem Pharmacol 107:73–146

    Google Scholar 

  • Szabo B, Hedler L, Starke K (1986) Dopamine, receptor agonist and alpha-2 adrenoceptor antagonist effects of fenoldopam in rabbits. J Pharmacol Exp Ther 239: 881–886

    Google Scholar 

  • Willems JL, Buylaert WA, Lefevbre RA, Bogaert MJ (1985) Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system. Pharmacol Rev 37:165–215

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Send offprint requests to P. Soares-da-Silva at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Soares-da-Silva, P. The effects of quinpirole and fenoldopam on the potassium-evoked overflow of endogenous dopamine and noradrenaline in dog mesenteric arteries. Naunyn-Schmiedeberg's Arch Pharmacol 341, 37–42 (1990). https://doi.org/10.1007/BF00195055

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00195055

Key words

Navigation